Clin2
NCT07459790Possibly a fitRecruiting

A new treatment for interstitial cystitis with Hunner's lesions

ICHunner Type Interstitial CystitisBladder Pain Syndrome

Treatments studied

Part of Kidney & urinary, Women’s health & pregnancy clinical trials.

This study tests a new treatment for women with interstitial cystitis (also called painful bladder syndrome) who have Hunner's lesions (specific sores in the bladder lining). The goal is to see if the new treatment can reduce pelvic pain, frequent urination, and other symptoms.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2/Phase 3
Enrollment
180 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You are a woman aged 18 to 65.
  • You have had pelvic pain linked to filling or emptying your bladder for at least 12 months, along with frequent urination day and night.
  • Your doctor has confirmed you have Hunner's lesions (sores) in your bladder during a special examination.
  • You are able to regularly fill out a diary and attend study visits.
  • If you could become pregnant, you must have a negative pregnancy test and use reliable birth control throughout the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07391306Recruiting· Phase 2/Phase 3
New treatment for interstitial cystitis without Hunner's lesions

This trial is testing a new treatment for people with painful bladder syndrome (interstitial cystitis) who do not have Hunner's lesions in their bladder. It aims to see if the treatment can help reduce pelvic pain and frequent urination.

Moscow
NCT06394830Recruiting· Phase 2
Testing VNX001 for bladder pain syndrome

This study tests a new treatment (VNX001) for people with interstitial cystitis or bladder pain syndrome (IC/BPS). You must have already taken part in an earlier study of this drug to join. The goal is to see if it safely reduces bladder pain.

Tucson, Arizona
NCT05737121Recruiting· Phase 2
Study drug for bladder pain compared with lidocaine, heparin, or placebo

This Phase 2 trial tests VNX001 to see if it helps people with interstitial cystitis/bladder pain syndrome (IC/BPS) compared with its separate ingredients (lidocaine and heparin) or a placebo (inactive treatment). You may be eligible if you have had IC/BPS for months and recently had a moderate-to-severe bladder pain flare.

Escondido, California
NCT06204874Recruiting
Nerve stimulation for bladder pain in women

This trial tests a new nerve stimulation approach for women with bladder pain syndrome. It aims to find a gentler way to reduce pain and urgency without surgery.

Bethesda, Maryland
NCT06719232Recruiting
Testing a new way to give bladder treatment without a catheter

This study tests a catheter-free method for delivering medication directly into the bladder. It may help patients with bladder pain, recurrent infections, bladder cancer, or cystitis after radiation or chemotherapy.

Budapest
NCT06299683Recruiting
Pain type and bladder pain syndrome treatment study

This study is testing if the type of pain you feel can help predict which treatments work best for interstitial cystitis (a condition that causes bladder pain and pressure). It may help match you with more effective care.

Franklin, Tennessee

Hear when a new Bladder Pain Syndrome trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.